Herbalife (NYSE:HLF) Issues Earnings Results

Herbalife (NYSE:HLF) posted its earnings results on Monday. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.02, FiscalAI reports. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.31 billion. Herbalife had a net margin of 3.16% and a negative return on equity of 43.90%. The company’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.50 earnings per share.

Here are the key takeaways from Herbalife’s conference call:

• Third-quarter results exceeded guidance, with net sales up 6% reported and 7.6% in constant currency, marking the fifth consecutive quarter of growth. Adjusted EBITDA rose to $182 million, while the margin expanded 70 basis points to 13.5%.
• Herbalife raised its full-year net sales outlook to 4.9%-5.9% reported growth and 5.3%-6.3% constant-currency growth, while increasing constant-currency adjusted EBITDA guidance to $700 million-$720 million. India was a major driver, with local-currency sales up 52% and volume up nearly 50%.
• The company ended the quarter with net leverage at 2.0 times, reduced debt by $88 million, and expects lower interest expense following its refinancing. Management also plans to begin executing a newly authorized $250 million share-repurchase program in the fourth quarter.
• Management outlined a growth strategy centered on dedicated support for nutrition clubs, a modular customer-engagement technology platform beginning with the 24 Games in early 2027, and expanding Bioniq into personalized nutrition, sports performance, and healthy lifespan products. It is also positioning existing products for consumers using GLP-1 medications.
• Management cautioned that fourth-quarter adjusted EBITDA guidance implies a lower margin than in the third quarter and said further margin expansion will be gradual amid input-cost monitoring. EMEA and China partially offset regional growth, while foreign exchange remains a meaningful headwind.

Herbalife Stock Performance

HLF stock opened at $13.41 on Tuesday. The company has a market capitalization of $1.41 billion, a P/E ratio of 8.65, a PEG ratio of 0.44 and a beta of 0.78. The company has a fifty day moving average price of $12.73 and a 200-day moving average price of $13.99. Herbalife has a 52-week low of $7.68 and a 52-week high of $20.40.

Key Herbalife News

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Sales and volume growth strengthened. Third-quarter net sales reached approximately $1.35 billion, beating expectations, while reported sales growth was 6.0% and volume points accelerated. Herbalife also described the quarter as its fifth consecutive period of expansion. Herbalife third-quarter results
• Positive Sentiment: Management raised its sales outlook. The improved guidance suggests Herbalife expects momentum to continue, supporting the investment case that its turnaround is gaining traction. Strong profitability and robust operating cash flow could also allow the company to return capital to shareholders. Herbalife outlook and turnaround
• Neutral Sentiment: Profitability improved but remains closely watched. Adjusted earnings were $0.64 per share, up from $0.50 a year earlier. That exceeded the consensus estimate cited by some outlets at $0.62, but missed the higher Zacks estimate of $0.73, creating a mixed earnings signal. Herbalife earnings estimate
• Negative Sentiment: Leadership and margin risks cloud the recovery. The CEO’s departure and related leadership changes introduce execution uncertainty. In addition, management’s softer margin outlook could limit future earnings growth even if revenue and customer volume continue to improve. Herbalife leadership changes

Wall Street Analyst Weigh In

HLF has been the topic of several recent research reports. UBS Group set a $21.00 price objective on Herbalife in a report on Thursday, September 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Herbalife in a report on Thursday, October 22nd. Citigroup reiterated a “buy” rating and issued a $17.00 target price (down from $21.00) on shares of Herbalife in a research report on Friday, August 7th. Zacks Research lowered Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 29th. Finally, Wall Street Zen cut Herbalife from a “buy” rating to a “hold” rating in a report on Sunday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Herbalife presently has an average rating of “Moderate Buy” and a consensus target price of $17.67.

Herbalife declared that its board has initiated a stock buyback plan on Tuesday, September 8th that allows the company to repurchase $250 million in outstanding shares. This buyback authorization allows the company to repurchase up to 19.3% of its shares through open market purchases. Share buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Herbalife Company Profile

Herbalife Ltd. (NYSE: HLF) is a global nutrition and wellness company that develops and distributes products through a network of independent members and distributors. Its offerings include meal-replacement shakes, protein and other dietary supplements, vitamins, sports nutrition products, and personal-care items.

Founded in 1980 by Mark Hughes, Herbalife sells its products through direct-selling channels rather than primarily through traditional retail stores. Independent distributors market the products, provide product guidance, and may operate nutrition clubs or similar community-based businesses.

The company serves customers across numerous markets in North America, Latin America, Europe, Asia-Pacific, and other regions.